Life Healthcare (LHC) - Net Assets

Latest as of September 2025: ZAC12.14 Billion ZAC ≈ $6.45 Million USD

Based on the latest financial reports, Life Healthcare (LHC) has net assets worth ZAC12.14 Billion ZAC (≈ $6.45 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (ZAC25.69 Billion ≈ $13.65 Million USD) and total liabilities (ZAC13.55 Billion ≈ $7.20 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check LHC financial resilience to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	ZAC12.14 Billion
% of Total Assets	47.26%
Annual Growth Rate	9.29%
5-Year Change	-36.66%
10-Year Change	78.61%
Growth Volatility	32.67

Life Healthcare - Net Assets Trend (2009–2025)

This chart illustrates how Life Healthcare's net assets have evolved over time, based on quarterly financial data. Also explore Life Healthcare asset portfolio for the complete picture of this company's asset base.

Annual Net Assets for Life Healthcare (2009–2025)

The table below shows the annual net assets of Life Healthcare from 2009 to 2025. For live valuation and market cap data, see LHC market cap overview.

Year	Net Assets	Change
2025-09-30	ZAC12.14 Billion ≈ $6.45 Million	-10.15%
2024-09-30	ZAC13.51 Billion ≈ $7.18 Million	-36.52%
2023-09-30	ZAC21.29 Billion ≈ $11.31 Million	+7.20%
2022-09-30	ZAC19.86 Billion ≈ $10.55 Million	+3.59%
2021-09-30	ZAC19.17 Billion ≈ $10.19 Million	+4.89%
2020-09-30	ZAC18.28 Billion ≈ $9.71 Million	+4.50%
2019-09-30	ZAC17.49 Billion ≈ $9.30 Million	+7.96%
2018-09-30	ZAC16.20 Billion ≈ $8.61 Million	+4.19%
2017-09-30	ZAC15.55 Billion ≈ $8.26 Million	+128.76%
2016-09-30	ZAC6.80 Billion ≈ $3.61 Million	+5.43%
2015-09-30	ZAC6.45 Billion ≈ $3.43 Million	+9.29%
2014-09-30	ZAC5.90 Billion ≈ $3.14 Million	+5.23%
2013-09-30	ZAC5.61 Billion ≈ $2.98 Million	+14.94%
2012-09-30	ZAC4.88 Billion ≈ $2.59 Million	+11.26%
2011-09-30	ZAC4.38 Billion ≈ $2.33 Million	+24.73%
2010-09-30	ZAC3.52 Billion ≈ $1.87 Million	+19.96%
2009-09-30	ZAC2.93 Billion ≈ $1.56 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Life Healthcare's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 173.9% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (September 2025)

Component	Amount	Percentage
Common Stock	ZAC10.51 Billion	92.35%
Other Comprehensive Income	ZAC-315.00 Million	-2.77%
Other Components	ZAC2.72 Billion	23.88%
Total Equity	ZAC11.38 Billion	100.00%

Life Healthcare Competitors by Market Cap

The table below lists competitors of Life Healthcare ranked by their market capitalization.

Company	Market Cap
VNDIRECT Securities Corp VN:VND	$963.00 Million
Triveni Engineering & Industries Limited NSE:TRIVENI	$963.49 Million
Suning Universal Co Ltd SHE:000718	$963.62 Million
Jiangsu Fasten Co Ltd SHE:000890	$963.77 Million
GH Research PLC NASDAQ:GHRS	$962.70 Million
Permian Basin Royalty Trust NYSE:PBT	$962.47 Million
MA Financial Group Ltd AU:MAF	$962.41 Million
Allianz Malaysia Bhd KLSE:1163	$962.24 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Life Healthcare's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 12,539,000,000 to 11,377,000,000, a change of -1,162,000,000 (-9.3%).
Net income of 3,864,000,000 contributed positively to equity growth.
Dividend payments of 5,233,000,000 reduced retained earnings.
Share repurchases of 407,000,000 reduced equity.
New share issuances of 3,000,000 increased equity.
Other comprehensive income increased equity by 188,000,000.
Other factors increased equity by 423,000,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	ZAC3.86 Billion	+33.96%
Dividends Paid	ZAC5.23 Billion	-46.0%
Share Repurchases	ZAC407.00 Million	-3.58%
Share Issuances	ZAC3.00 Million	+0.03%
Other Comprehensive Income	ZAC188.00 Million	+1.65%
Other Changes	ZAC423.00 Million	+3.72%
Total Change	ZAC-	-9.27%

Book Value vs Market Value Analysis

This analysis compares Life Healthcare's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 161.66x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 688.13x to 161.66x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2009-09-30	ZAC1.84	ZAC1266.00	x
2010-09-30	ZAC2.31	ZAC1266.00	x
2011-09-30	ZAC2.73	ZAC1266.00	x
2012-09-30	ZAC3.17	ZAC1266.00	x
2013-09-30	ZAC3.64	ZAC1266.00	x
2014-09-30	ZAC3.85	ZAC1266.00	x
2015-09-30	ZAC4.33	ZAC1266.00	x
2016-09-30	ZAC4.88	ZAC1266.00	x
2017-09-30	ZAC10.95	ZAC1266.00	x
2018-09-30	ZAC10.24	ZAC1266.00	x
2019-09-30	ZAC11.08	ZAC1266.00	x
2020-09-30	ZAC11.69	ZAC1266.00	x
2021-09-30	ZAC12.39	ZAC1266.00	x
2022-09-30	ZAC12.89	ZAC1266.00	x
2023-09-30	ZAC13.90	ZAC1266.00	x
2024-09-30	ZAC8.63	ZAC1266.00	x
2025-09-30	ZAC7.83	ZAC1266.00	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Life Healthcare utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 33.96%
The company demonstrates strong efficiency in generating profits from shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 15.39%
• Asset Turnover: 0.98x
• Equity Multiplier: 2.26x
Recent ROE (33.96%) is above the historical average (25.67%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2009	40.39%	11.82%	1.15x	2.97x	ZAC705.27 Million
2010	29.32%	9.51%	1.12x	2.76x	ZAC550.34 Million
2011	42.42%	15.21%	1.16x	2.41x	ZAC1.14 Billion
2012	37.96%	13.68%	1.18x	2.35x	ZAC1.10 Billion
2013	38.92%	14.87%	1.19x	2.20x	ZAC1.31 Billion
2014	57.89%	21.26%	1.10x	2.47x	ZAC2.29 Billion
2015	36.11%	12.74%	0.92x	3.08x	ZAC1.35 Billion
2016	29.46%	9.85%	0.94x	3.19x	ZAC1.07 Billion
2017	5.66%	3.91%	0.57x	2.55x	ZAC-624.00 Million
2018	10.56%	6.71%	0.60x	2.62x	ZAC83.40 Million
2019	15.87%	10.01%	0.68x	2.32x	ZAC950.20 Million
2020	0.22%	0.15%	0.59x	2.50x	ZAC-1.67 Billion
2021	9.71%	6.52%	0.66x	2.26x	ZAC-52.60 Million
2022	8.17%	7.46%	0.49x	2.25x	ZAC-343.60 Million
2023	1.31%	1.17%	0.50x	2.26x	ZAC-1.76 Billion
2024	38.50%	18.72%	1.06x	1.94x	ZAC3.57 Billion
2025	33.96%	15.39%	0.98x	2.26x	ZAC2.73 Billion

Industry Comparison

This section compares Life Healthcare's net assets metrics with peer companies in the Medical Care Facilities industry.

Industry Context

Industry: Medical Care Facilities
Average net assets among peers: $2,270,851,000
Average return on equity (ROE) among peers: 19.52%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Life Healthcare (LHC)	ZAC12.14 Billion	40.39%	1.12x	$962.82 Million
AfroCentric Investment Corp (ACT)	$1.12 Billion	15.19%	0.39x	$52.51 Million
Netcare (NTC)	$3.42 Billion	23.85%	0.84x	$1.11 Billion

About Life Healthcare

JSE:LHC South Africa Medical Care Facilities

Market Cap

$962.82 Million

ZAC1.81 Trillion ZAC

Market Cap Rank

#9334 Global

#67 in South Africa

Share Price

ZAC1266.00

Change (1 day)

+1.44%

52-Week Range

ZAC1050.00 - ZAC1499.00

All Time High

ZAC3062.35